Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Klaus R. Dr Veitinger currently holds 19,750 shares of INTERCEPT PHARMACEUTICALS INC (ICPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Klaus R. Dr Veitinger has been a net seller of ICPT stock. They have purchased $0 and sold $8.6M worth of shares.
Klaus R. Dr Veitinger's most recent insider trade was on Jun 11, 2024, when they sold 19,750 shares at $0.00 per share.
Klaus R. Dr Veitinger serves as Executive at INTERCEPT PHARMACEUTICALS INC (ICPT). They have executed 178 insider transactions totaling $8.6M over their tenure at the company.
Klaus R. Dr Veitinger holds the position of Executive at INTERCEPT PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Klaus R. Dr Veitinger has shown a selling trading pattern, with $0 in total purchases and $8.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Klaus R. Dr Veitinger was on Mar 28, 2019, when they sold $755.6K worth of TCDA shares. This transaction involved 22,100 shares at $34.19 per share.
Klaus R. Dr Veitinger currently owns 19,750 shares of INTERCEPT PHARMACEUTICALS INC (ICPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Klaus R. Dr Veitinger's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Klaus R. Dr Veitinger has 178 Form 4 filings on record as an insider at INTERCEPT PHARMACEUTICALS INC.
Set alerts for Klaus R. Dr Veitinger and 40,000+ other insiders.